Additionally, Almirall has also received German approval for Actikerall as a treatment hyperkeratotic actinic keratosis (grade I/II) in adult patients.
Almirall is set to launch Actikerall in German market on 15 July 2011, as part of its plan to strengthen its presence in European market.
Almirall Germany, Austria and Switzerland managing director Farid Taha said Almirall aims to provide innovative solutions for patients.
"With the launch of Actikerall we will bring a new topical solution for non-melanoma skin cancer sufferers," Taha said.